NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test receives Emergency Use Authorization by FDA The 4-plex test utilizes the high-throughput, automated testing capabilities of the NeuMoDx systems, which has ...

12.1 United States Medicare System: Clinical Laboratory Fees Schedule ...

(RTTNews) - Qiagen N.V. (QGEN) announced Monday that the U.S. Food and Drug Administration or FDA has granted Emergency Use Authorization for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test. The ...

VANCOUVER, British Columbia & KNOXVILLE, Tenn.--(BUSINESS WIRE)--Augurex Life Sciences Corp. (“Augurex”) today announced the launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents (ASRs), ...

A new blood test called the Tick-Borne Disease Serochip (TBD Serochip) promises to revolutionize the diagnosis of tick-borne disease by offering a single test to identify and distinguish between ...

Beverly, Mass.-based Lexagene Holdings Inc. has developed a genetic analyzer with multiplex testing capability that would enable it to determine whether a patient has COVID-19, influenza or another ...